influenza
DESCRIPTION
INFLUENZA. VIROLOGY OF INFLUENZA. Subtypes: A - Causes outbreak B - Causes outbreaks C - Does not cause outbreaks. PATHOGENICITY. High pathogenicity avian influenza (HPAI) Causes severe disease in poultry Contains subtypes H5 or H7 Low pathogenicity avian influenza (LPAI) - PowerPoint PPT PresentationTRANSCRIPT
![Page 1: INFLUENZA](https://reader036.vdocuments.us/reader036/viewer/2022062409/56814c3e550346895db942a6/html5/thumbnails/1.jpg)
INFLUENZA
![Page 2: INFLUENZA](https://reader036.vdocuments.us/reader036/viewer/2022062409/56814c3e550346895db942a6/html5/thumbnails/2.jpg)
VIROLOGY OF INFLUENZA
Subtypes:
A - Causes outbreak
B - Causes outbreaks
C - Does not cause outbreaks
![Page 3: INFLUENZA](https://reader036.vdocuments.us/reader036/viewer/2022062409/56814c3e550346895db942a6/html5/thumbnails/3.jpg)
PATHOGENICITY
• High pathogenicity avian influenza (HPAI)– Causes severe disease in poultry
– Contains subtypes H5 or H7
• Low pathogenicity avian influenza (LPAI)– Causes mild disease in poultry
– Contains other H subtypes • Includes non-HPAI H5 and H7
• LPAI H5 or H7 subtypes can mutate into HPAI
Center for Food Security and Public Health, Iowa State University, 2013
![Page 4: INFLUENZA](https://reader036.vdocuments.us/reader036/viewer/2022062409/56814c3e550346895db942a6/html5/thumbnails/4.jpg)
Immunogenic Components of Immunogenic Components of the Influenza Virusthe Influenza Virus
• Surface glycoproteins, 15 hemagglutinin (H1-H15), nine neurominidases (N1-N9)
• H1-H3 and N1N2 established in humans
• Influenza characterized by combination of H and N glycoproteins 1917 pandemic - H1N1
2004 avian influenza - H5N1
2009 H1N1
• Antigenic mix determines severity of disease
• Human response specific to hemagglutinin and neurominidase glycoproteins
![Page 5: INFLUENZA](https://reader036.vdocuments.us/reader036/viewer/2022062409/56814c3e550346895db942a6/html5/thumbnails/5.jpg)
Antigenic Drift and Shift
• Antigenic drift– Small changes in influenza virus due to
point mutations accumulated during virus replication
• Antigenic shift– Abrupt change in virus subtype
• Genetic reassortment between subtypes• Direct transfer of virus • Re-emergence of virus
Center for Food Security and Public Health, Iowa State University, 2013
![Page 6: INFLUENZA](https://reader036.vdocuments.us/reader036/viewer/2022062409/56814c3e550346895db942a6/html5/thumbnails/6.jpg)
RESERVOIRS
Domestic and wild birdsWaterfowl and shorebirds
Natural reservoirs for influenza ACarry all known H and N antigens
– Usually in the LPAI form
Predominant subtypes change periodically
Pigs Wet markets (live animals)
Center for Food Security and Public Health, Iowa State University, 2013
![Page 7: INFLUENZA](https://reader036.vdocuments.us/reader036/viewer/2022062409/56814c3e550346895db942a6/html5/thumbnails/7.jpg)
Figure 1. Natural hosts of influenza viruses
Nicholson et al. Influenza. Lancet 362:1734, 2003
![Page 8: INFLUENZA](https://reader036.vdocuments.us/reader036/viewer/2022062409/56814c3e550346895db942a6/html5/thumbnails/8.jpg)
Nicholson et al. Influenza. Lancet 362:1735, 2003
Figure 2. Origin of antigenic shift and pandemic influenza. The segmented nature of the influenza A genome, which has eight genes, facilitates reassortment; up to 256 gene combinations are possible during coinfection with human and non-human viruses. Antigenic shift can arise when genes encoding at least the haemagglutinin surface glycoprotein are introduced into people, by direct transmission of an avian virus from birds, as occurred with H5N1 virus, or after genetic reassortment in pigs, which support the growth of both avian and human viruses.
![Page 9: INFLUENZA](https://reader036.vdocuments.us/reader036/viewer/2022062409/56814c3e550346895db942a6/html5/thumbnails/9.jpg)
Morbidity and Mortality: Birds
• Domesticated poultry– HPAI morbidity and mortality rates approach
90-100%
• Wild birds– Typically asymptomatic
• Some H5N1 viruses may cause death
Center for Food Security and Public Health, Iowa State University, 2013
![Page 10: INFLUENZA](https://reader036.vdocuments.us/reader036/viewer/2022062409/56814c3e550346895db942a6/html5/thumbnails/10.jpg)
Influenza Epidemics
• Epidemic requirements1. New influenza subtype must emerge in
species with little to no immunity
2. Virus must produce disease in that species
3. Sustainable transmission must occur in new species
• Note: Asian lineage H5N1 has NOT met third criteria in humans
Center for Food Security and Public Health, Iowa State University, 2013
![Page 11: INFLUENZA](https://reader036.vdocuments.us/reader036/viewer/2022062409/56814c3e550346895db942a6/html5/thumbnails/11.jpg)
Transmission in Poultry
• In an infected flock, virus can spread in multiple ways– Fecal-oral– Aerosol– Fomites– Mechanical vectors
• Virus introduction– Migratory birds– Infected poultry, pet birds
Center for Food Security and Public Health, Iowa State University, 2013
![Page 12: INFLUENZA](https://reader036.vdocuments.us/reader036/viewer/2022062409/56814c3e550346895db942a6/html5/thumbnails/12.jpg)
Influenza Virus Survival
• Virus persistence in aquatic environments– Weeks to months – Preferred conditions
• Low temperatures, brackish water
– May survive indefinitely when frozen
• Virus persistence in feces– Weeks to months
Center for Food Security and Public Health, Iowa State University, 2013
![Page 13: INFLUENZA](https://reader036.vdocuments.us/reader036/viewer/2022062409/56814c3e550346895db942a6/html5/thumbnails/13.jpg)
SURVEILLANCE FOR FLU
![Page 14: INFLUENZA](https://reader036.vdocuments.us/reader036/viewer/2022062409/56814c3e550346895db942a6/html5/thumbnails/14.jpg)
http://www.cdc.gov/h1n1flu/updates/us/
![Page 15: INFLUENZA](https://reader036.vdocuments.us/reader036/viewer/2022062409/56814c3e550346895db942a6/html5/thumbnails/15.jpg)
http://www.cdc.gov/h1n1flu/updates/us/ - real-time
![Page 16: INFLUENZA](https://reader036.vdocuments.us/reader036/viewer/2022062409/56814c3e550346895db942a6/html5/thumbnails/16.jpg)
Update: influenza activity – U.S., Sept 29-Dec 7, 2013. MMWR 62(50):1034, 2013.
![Page 17: INFLUENZA](https://reader036.vdocuments.us/reader036/viewer/2022062409/56814c3e550346895db942a6/html5/thumbnails/17.jpg)
The figure shows peak influenza activity for the United States by month for the 1976-77 through 2008-09 influenza seasons. The month with the highest percentage of cases (nearly 50%) was February, followed by January with 20% and March and December, with approximately 15% of all cases.
Prevention and control of seasonal influenza with vaccines. MMWR 58(RR-8):5, 2009
![Page 18: INFLUENZA](https://reader036.vdocuments.us/reader036/viewer/2022062409/56814c3e550346895db942a6/html5/thumbnails/18.jpg)
http://www.milbank.org/reports/0601fauci/0601Fauci.pdf
![Page 19: INFLUENZA](https://reader036.vdocuments.us/reader036/viewer/2022062409/56814c3e550346895db942a6/html5/thumbnails/19.jpg)
CLINICAL OUTCOMES OF INFLUENZA INFECTION
• AsymptomaticAsymptomatic
• SymptomaticSymptomatic
Respiratory syndrome - mild to severe
Gastrointestinal symptoms
Involvement of major organs - brain, heart, etc.
Death
![Page 20: INFLUENZA](https://reader036.vdocuments.us/reader036/viewer/2022062409/56814c3e550346895db942a6/html5/thumbnails/20.jpg)
Factors Influencing the Response to Influenza
• Age
• Pre-existing immunity (some crossover)
• Smoking
• Concurrent other health conditions
• Immunosuppression
• Pregnancy
![Page 21: INFLUENZA](https://reader036.vdocuments.us/reader036/viewer/2022062409/56814c3e550346895db942a6/html5/thumbnails/21.jpg)
Treatment in Humans
• Antiviral drugs– Amantadine– Rimantadine– Zanamivir– Oseltamivir
• Currently circulating H5N1 viruses may be resistant to amantadine, rimantadine
Center for Food Security and Public Health, Iowa State University, 2013
![Page 22: INFLUENZA](https://reader036.vdocuments.us/reader036/viewer/2022062409/56814c3e550346895db942a6/html5/thumbnails/22.jpg)
The H1N1 Epidemic
![Page 23: INFLUENZA](https://reader036.vdocuments.us/reader036/viewer/2022062409/56814c3e550346895db942a6/html5/thumbnails/23.jpg)
![Page 24: INFLUENZA](https://reader036.vdocuments.us/reader036/viewer/2022062409/56814c3e550346895db942a6/html5/thumbnails/24.jpg)
Kaplan K. How the new virus came to be. LA Times, 14 Sept, 2009; latimes.com/health
![Page 25: INFLUENZA](https://reader036.vdocuments.us/reader036/viewer/2022062409/56814c3e550346895db942a6/html5/thumbnails/25.jpg)
RECOMMENDATIONS TO PREVENT FLU
![Page 26: INFLUENZA](https://reader036.vdocuments.us/reader036/viewer/2022062409/56814c3e550346895db942a6/html5/thumbnails/26.jpg)
STRATEGIES TO PREVENT FLU (1)• COVER MOUTH AND NOSE WHEN
SNEEZING
• WASH HANDS FREQUENTLY WITH SOAP AND WATER OR ALCOHOL
• AVOID TOUCHING EYES, NOSE AND MOUTH
• AVOID CONTACT WITH SICK PEOPLE
• AVOID CROWDED CONGESTED ENVIRONMENTS
![Page 27: INFLUENZA](https://reader036.vdocuments.us/reader036/viewer/2022062409/56814c3e550346895db942a6/html5/thumbnails/27.jpg)
STRATEGIES TO PREVENT FLU (2)
• IF SICK STAY HOME, DON’T EXPOSE OTHERS
• FOLLOW PUBLIC HEALTH ADVICE; e.g. school closures etc.
• GET FLU SHOT(S)
• TAKE ANTIVIRAL DRUGS IF PHYSICIAN RECOMMENDS